Celularity CELU
NASDAQ CELU
$1.05 +0.03 (+2.94%)
At close: Oct 22, 2026 · 4:00 PM EDT

Celularity (CELU) Long-Term Debt Repayments (2025)

Updated

Celularity's Long-Term Debt Repayments was $1.52 million in Q4 2025, down 77.5% from the prior quarter.

Analysis

Celularity (CELU) Long-Term Debt Repayments (2025) Analysis & Trends

For FY2025, Long-Term Debt Repayments at Celularity came in at $8.49 million.

  • Long-Term Debt Repayments shows a four-year compound annual growth rate of 14.1% (FY2021 to FY2025).
  • In earlier years, Long-Term Debt Repayments was $5 million in FY2021.
  • Quarterly Long-Term Debt Repayments has moved between $42,000 (Q1 2025) and $6.75 million (Q3 2025) over five years.
  • Per Business Quant data, CELU's Long-Term Debt Repayments in the three quarters before Q4 2025 was $6.75 million (Q3 2025), $179,000 (Q2 2025) and $42,000 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 1.00 Mn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 2.00 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 2.46 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 17.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Celularity 30.75 Mn 23.50 Mn 3.09 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.52 Mn
Mar 31, 2025 42,000.00
API Access

Celularity Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=CELU&period=max&api_key=YOUR_API_KEY